The development of store operated calcium channel monoclonal antibody inhibitors as a therapeutic option for breast cancer treatment [ 2011 - 2013 ]

Research Grant

Researchers: Prof Gregory Monteith (Principal investigator) ,  Prof Ross Barnard ,  Prof Sarah Roberts-Thomson

Brief description Despite recent advances in the treatment of breast cancer, a significant proportion of women with this disease receive little benefit from currently available treatments and die from breast cancer. Hence, new therapies for the breast cancers with the poorest prognosis are needed. This grant exploits our earlier finding that a specific calcium channel is a likely therapeutic target for breast cancer. Funding from this grant will be used to develop an inhibitory monoclonal antibody to this target.

Funding Amount $AUD 230,753.75

Funding Scheme NHMRC Development Grants

Notes Development Grant